Javascript must be enabled to continue!
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
View through CrossRef
Abstract
Background
Wnt-catenin signaling antagonists sclerostin and dickkopf-related protein-1 (Dkk-1) inhibit bone formation and are involved in the pathogenesis of postmenopausal osteoporosis (PO). However, the association between sclerostin and Dkk-1 and bone mineral density (BMD) in women with PO remains unclear.
Objective
This study aimed to determine the association between sclerostin and Dkk-1 and BMD, bone microarchitecture, and bone strength in PO.
Methods
Trabecular bone specimens were obtained from the femoral heads of 76 Chinese women with PO who underwent hip arthroplasty for femoral neck fractures. Micro-computed tomography (Micro-CT) was used to assess the BMD and bone microarchitecture of the trabecular bone. Subsequently, a mechanical test was performed. Finally, sclerostin and Dkk-1 in the bone were measured by enzyme-linked immunosorbent (Elisa) assay. Serum ionized serum ionised calcium, propeptide of type 1 collagen, C-terminal β-telopeptide of type-1 collagen, sclerostin, and Dkk-1 were also detected.
Results
Bone sclerostin was positively correlated with serum ionised calcium, serum sclerostin, BMD, bone volume/tissue volume (BV/TV), trabecular number (Tb.N), maximum compressive force, and yield strength (r = 0.32, 0.906, 0.355, 0.401, 0.329, 0.355, and 0.293, respectively, P < 0.05) and negatively correlated with age and trabecular separation (Tb.Sp) (r = − 0.755 and − 0.503, respectively, P < 0.05). Bone Dkk-1 was positively correlated with serum ionised calcium, serum Dkk-1, BMD, BV/TV, trabecular thickness, Tb.N, maximum compressive force, yield strength, and Young’s modulus (r = 0.38, 0.809, 0.293, 0.293, 0.228, 0.318, 0.352, 0.315, and 0.266, respectively, P < 0.05) and negatively correlated with age and Tb.Sp (r = − 0.56 and − 0.38, respectively, P < 0.05). Serum levels of sclerostin and Dkk-1 reflected the levels of sclerostin and Dkk-1 in the bone.
Conclusion
Bone sclerostin and Dkk-1 were positively correlated with BMD in women with PO, and higher levels of bone sclerostin and Dkk-1 might predict better BMD, bone microarchitecture, and bone strength. The potential molecular mechanisms still require further study.
Springer Science and Business Media LLC
Title: Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
Description:
Abstract
Background
Wnt-catenin signaling antagonists sclerostin and dickkopf-related protein-1 (Dkk-1) inhibit bone formation and are involved in the pathogenesis of postmenopausal osteoporosis (PO).
However, the association between sclerostin and Dkk-1 and bone mineral density (BMD) in women with PO remains unclear.
Objective
This study aimed to determine the association between sclerostin and Dkk-1 and BMD, bone microarchitecture, and bone strength in PO.
Methods
Trabecular bone specimens were obtained from the femoral heads of 76 Chinese women with PO who underwent hip arthroplasty for femoral neck fractures.
Micro-computed tomography (Micro-CT) was used to assess the BMD and bone microarchitecture of the trabecular bone.
Subsequently, a mechanical test was performed.
Finally, sclerostin and Dkk-1 in the bone were measured by enzyme-linked immunosorbent (Elisa) assay.
Serum ionized serum ionised calcium, propeptide of type 1 collagen, C-terminal β-telopeptide of type-1 collagen, sclerostin, and Dkk-1 were also detected.
Results
Bone sclerostin was positively correlated with serum ionised calcium, serum sclerostin, BMD, bone volume/tissue volume (BV/TV), trabecular number (Tb.
N), maximum compressive force, and yield strength (r = 0.
32, 0.
906, 0.
355, 0.
401, 0.
329, 0.
355, and 0.
293, respectively, P < 0.
05) and negatively correlated with age and trabecular separation (Tb.
Sp) (r = − 0.
755 and − 0.
503, respectively, P < 0.
05).
Bone Dkk-1 was positively correlated with serum ionised calcium, serum Dkk-1, BMD, BV/TV, trabecular thickness, Tb.
N, maximum compressive force, yield strength, and Young’s modulus (r = 0.
38, 0.
809, 0.
293, 0.
293, 0.
228, 0.
318, 0.
352, 0.
315, and 0.
266, respectively, P < 0.
05) and negatively correlated with age and Tb.
Sp (r = − 0.
56 and − 0.
38, respectively, P < 0.
05).
Serum levels of sclerostin and Dkk-1 reflected the levels of sclerostin and Dkk-1 in the bone.
Conclusion
Bone sclerostin and Dkk-1 were positively correlated with BMD in women with PO, and higher levels of bone sclerostin and Dkk-1 might predict better BMD, bone microarchitecture, and bone strength.
The potential molecular mechanisms still require further study.
Related Results
Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease
Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease
Abstract
Background
Coronary tortuosity (CT) is commonly encountered in postmenopausal females and is usually present without ob...
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Osteoporosis is a bone disease characterized by decreased bone density. The incidence of osteoporosis increases with age, especially age ≥ 50 years. Research from the International...
Serum sclerostin level in premenopausal women with rheumatoid arthritis: relation to disease activity, fracture risk and bone mineral density
Serum sclerostin level in premenopausal women with rheumatoid arthritis: relation to disease activity, fracture risk and bone mineral density
Abstract
Background
Rheumatoid arthritis (RA) is associated with increased risk of fractures due to decreased bone mass. ...
Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus
Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus
Abstract
Objectives
Diabetes mellitus (DM) is widely known to have a detrimental effect on bone health and is associated with in...
Expression and methylation of Dickkopf‐1 in the pathogenesis and malignant transformation of oral submucous fibrosis
Expression and methylation of Dickkopf‐1 in the pathogenesis and malignant transformation of oral submucous fibrosis
AbstractBackgroundDickkopf‐1 is an inhibitor of the Wnt/β‐catenin pathway, but the role of Dickkopf‐1 in oral submucous fibrosis remains unclear. We evaluated the protein expressio...
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
The role of sclerostin in the formation of cardiovascular calcifi cation in chronic kidney disease C5D
The role of sclerostin in the formation of cardiovascular calcifi cation in chronic kidney disease C5D
THE AIM: to study the relationship of blood sclerostin with clinical parameters and its influence on the probability of detection of cardiovascular calcification in patients with C...
The Relationship between Sclerostin and Kidney Transplantation Mineral Bone Disorders: A Molecule of Controversies
The Relationship between Sclerostin and Kidney Transplantation Mineral Bone Disorders: A Molecule of Controversies
AbstractKidney transplantation is the most effective treatment option for most patients with end-stage kidney disease due to reduced mortality, decreased cardiovascular events and ...

